Abstract:Y-90 radioembolization is an increasingly utilized treatment for both primary and metastatic malignancy in the liver. Understanding the biophysical properties, dosing concerns, and imaging appearance of this treatment is important for interventional radiologists and nuclear medicine physicians to provide important therapy. Y-90 radioembolization is efficacious and safe, although the possibility of complications does exist. This article provides a comprehensive in-depth discussion about the indications for Y-90 radioembolization, reviews the role of preprocedural angiography and MAA scans, illustrates different dosing techniques, compares and contrasts resin and glass microspheres, and confers potential complications.
disease, unilateral hepatic artery embolization can be utilized to safely deliver treatment to both lobes via intrahepatic collateral formation. This study compares the effectiveness of therapy delivery to tumors supplied by the native hepatic artery to those supplied by intrahepatic collaterals following unilateral artery RE. Materials: A single-institution retrospective review was performed of all patients who underwent RE from 2009 through 2018. The study population included patients that underwent hepatic arterial embolization with the intent of treating via intrahepatic collaterals. Cross sectional imaging, both prior to and following RE, was reviewed to assess treatment response. Modified RECIST criteria was used to classify disease in each hepatic lobe as stable, improved, or worsened. Tumor response for lobes supplied by the native hepatic artery and for lobes supplied by intrahepatic collaterals were compared to assess for differences in treatment efficacy. Results: Of the 313 patients reviewed,15 patients underwent hepatic arterial embolization with the intent of redistribution, and 9 met inclusion criteria. Most patients were treated for metastatic colon cancer or hepatocellular carcinoma. In all but one patient, tumor response in both territories fell into the same mRECIST criteria category. In the one patient that showed a variant response, the territory treated via collaterals actually improved and the native territory progressed. Tumor response was not significantly different between the two tumor groups (p>0.05). Conclusions: Unilateral artery embolization can be used in the setting of variant arterial anatomy to deliver RE therapy to both hepatic lobes via intrahepatic collaterals. This decreases the risk of extrahepatic microsphere delivery without sacrificing tumor treatment response.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.